昂利康(002940.SZ)：美索巴莫注射液完成药品注册

Core Viewpoint - The company, Anglikang (002940.SZ), has received a drug registration certificate for Meisobam Injection from the National Medical Products Administration, indicating a significant regulatory approval for a new treatment option for acute musculoskeletal pain [1] Company Summary - Anglikang has announced the receipt of a drug registration certificate for Meisobam Injection, which is primarily used for the treatment of acute skeletal muscle pain or discomfort [1]